Close | |
Figure 1: (a) Baseline swept-source optical coherence tomography (SS-OCT) with subretinal fluid (SRF), subretinal hyperreflectivity (SHRM), and pigment epithelial detachment (PED). At 3 (b) and 6 months (c), after three intravitreal ziv-aflibercept (IVZ) injections on pro re nata (PRN) protocol, PED height reduction was noted with subretinal scarring. (d) SRF, SHRM, and notched PED. After three intravitreal bevacizumab (BVZ) injections (at baseline, 2nd and 4th month), SS-OCT showed resolution of SRF with persistent PED at 3 (e) and 6 months (f) |
|